Jelmyto
Payments companies reported to CMS as associated with Jelmyto. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Jelmyto, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Jelmyto
These are the largest totals companies reported as associated with Jelmyto. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Katie Murray | New York, NY | Urology | $284,026.48 |
| Vahan Kassabian | Roswell, GA | Urology | $59,820.84 |
| Marc Bjurlin | Kinston, NC | Urology | $49,323.78 |
| Vignesh Packiam | Iowa City, IA | Urology | $41,788.15 |
| Jennifer Linehan | Santa Monica, CA | Urology | $41,076.96 |
| Ravi Munver | Hackensack, NJ | Urology | $31,188.32 |
| Zachary Klaassen | Augusta, GA | Surgery | $29,702.19 |
| Sandip Prasad | Charleston, SC | Urology | $28,011.32 |
| Yair Lotan | Dallas, TX | Urology | $26,058.52 |
| Rian Dickstein | Hanover, MD | Urology | $21,548.46 |
Prescribed Jelmyto?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.